Back to results
US 2020/0215132 A1Published application
Oncolytic virus expressing a car t cell target and uses thereof
AssigneeCity of Hope
InventorsYuman Fong, Saul J. Priceman, Stephen J. Forman, Nanhai Chen, Anthony K. Park
Life of this patent
Estimating the term…
Abstract
An oncolytic poxvirus encoding a truncated human CD19 is used in conjunction with a chimeric antigen receptor to treat solid tumors.
Claims20
A recombinant oncolytic virus comprising a nucleotide sequence encoding a truncated human CD19 lacking a functional signaling domain, wherein the nucleotide sequence encoding the truncate CD19 is operably linked to a promoter.
Dependencies are inferred from the claim text.